Cargando…
Young blood products: emerging treatment for Alzheimer's disease?
Alzheimer's disease is the most common neurodegenerative disorder and no disease-modifying treatment is currently available. Research has shown that while brain neurogenesis continues in adult life, it declines with age. Using parabiosis, plasma transfusions and direct administration of neural...
Autores principales: | Khoury, Rita, Ghossoub, Elias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5950663/ https://www.ncbi.nlm.nih.gov/pubmed/29722305 http://dx.doi.org/10.4103/1673-5374.230277 |
Ejemplares similares
-
Selective serotonin reuptake inhibitors and Alzheimer’s disease
por: Mdawar, Bernadette, et al.
Publicado: (2019) -
Emerging perspectives on mitochondrial dysfunction and inflammation in Alzheimer’s disease
por: Yoo, Seung-Min, et al.
Publicado: (2020) -
New drug treatments show neuroprotective effects in Alzheimer's and Parkinson's diseases
por: Hölscher, Christian
Publicado: (2014) -
Human taeniasis/cysticercosis: a potentially emerging parasitic disease in Europe
por: Symeonidou, Isaia, et al.
Publicado: (2018) -
Alzheimer's disease: the silver tsunami of the 21(st) century
por: Sarkar, Ankita, et al.
Publicado: (2016)